Richard Harris

Award-winning journalist Richard Harris has reported on a wide range of topics in science, medicine and the environment since he joined NPR in 1986. In early 2014, his focus shifted from an emphasis on climate change and the environment to biomedical research.

Harris has traveled to all seven continents for NPR. His reports have originated from Timbuktu, the South Pole, the Galapagos Islands, Beijing during the SARS epidemic, the center of Greenland, the Amazon rain forest, the foot of Mt. Kilimanjaro (for a story about tuberculosis), and Japan to cover the nuclear aftermath of the 2011 tsunami.
In 2010, Harris' reporting revealed that the blown-out BP oil well in the Gulf of Mexico was spewing out far more oil than asserted in the official estimates. That revelation led the federal government to make a more realistic assessment of the extent of the spill.

Harris covered climate change for decades. He reported from the United Nations climate negotiations, starting with the Earth Summit in Rio de Janeiro in 1992, and including Kyoto in 1997 and Copenhagen in 2009. Harris was a major contributor to NPR's award-winning 2007-2008 "Climate Connections" series.

Over the course of his career, Harris has been the recipient of many prestigious awards. Those include the American Geophysical Union's 2013 Presidential Citation for Science and Society. He shared the 2009 National Academy of Sciences Communication Award and was a finalist again in 2011. In 2002, Harris was elected an honorary member of Sigma Xi, the scientific research society. Harris shared a 1995 Peabody Award for investigative reporting on NPR about the tobacco industry. Since 1988, the American Association for the Advancement of Science has honored Harris three times with its science journalism award.

Before joining NPR, Harris was a science writer for the San Francisco Examiner. From 1981 to 1983, Harris was a staff writer at The Tri-Valley Herald in Livermore, California, covering science, technology, and health issues related to the nuclear weapons lab in Livermore. He started his career as an AAAS Mass Media Science Fellow at the now-defunct Washington (DC) Star.

Harris is co-founder of the Washington, D.C., Area Science Writers Association, and is past president of the National Association of Science Writers. He serves on the board of the Council for the Advancement of Science Writing.

A California native, Harris returned to the University of California-Santa Cruz in 2012, to give a commencement address at Crown College, where he had given a valedictory address at his own graduation. He earned a bachelor's degree at the school in biology, with highest honors.

Pages

Shots - Health News
4:17 pm
Thu June 5, 2014

Quick DNA Tests Crack Medical Mysteries Otherwise Missed

Doctors used a rapid DNA test to identify a Wisconsin teen's unusual infection with Leptospira bacteria (yellow), which are common in the tropics.
CDC/Rob Weyant

Originally published on Sat June 7, 2014 8:07 am

Researchers are developing a radical way to diagnose infectious diseases. Instead of guessing what a patient might have, and ordering one test after another, this new technology starts with no assumptions.

The technology starts with a sample of blood or spinal fluid from an infected person and searches through all the DNA in it, looking for sequences that came from a virus, a bacterium, a fungus or even a parasite.

Read more
Shots - Health News
6:31 am
Sun June 1, 2014

Once A Year, Cancer Research News Comes In A Flood, Not A Trickle

Lots of basic science leads to some clinical trials and, if all goes well, new cancer treatments.
thelinke/iStockphoto

Originally published on Mon June 2, 2014 7:31 am

News about cancer therapies usually comes out in medical journals with the regular rhythm of an IV drip. But every now and then information comes out in a flood.

That's the case this weekend. The American Society of Clinical Oncology is holding its 50th annual meeting in Chicago. The convention typically attracts 30,000 attendees, making it one of the biggest cancer meetings of the year. And the amount of new information must be bewildering for even the most intrepid doctors.

Read more
Shots - Health News
1:28 pm
Thu May 29, 2014

Measles Hits Amish Communities, And U.S. Cases Reach 20-Year High

Measles was brought to Ohio's Amish communities by people returning from mission trips to the Philippines.
Chuck Crow The Plain Dealer/Landov

Originally published on Thu May 29, 2014 5:34 pm

Members of Amish communities in Ohio traveled to the Philippines for heartfelt reasons: They were there on service projects to help less fortunate people. Unfortunately, they came home with unwelcome hitchhikers: measles viruses.

Those travelers hadn't been vaccinated against this highly contagious disease, the Centers for Disease Control and Prevention said Thursday. As a result, they have triggered an outbreak of more than 130 cases, primarily among their unvaccinated friends and relatives in Amish communities.

Read more
Shots - Health News
1:21 pm
Thu May 22, 2014

Experimental Malaria Vaccine Blocks The Bad Guy's Exit

Red blood cells infected with the Plasmodium falciparum parasite. Plasmodium is the parasite that triggers malaria in people.
Gary D. Gaugler Science Source

Originally published on Thu May 22, 2014 5:46 pm

For the first time in decades, researchers trying to develop a vaccine for malaria have discovered a new target they can use to attack this deadly and common parasite.

Finding a target for attack is a far cry from having a vaccine. And the history of malaria vaccines is littered with hopeful ideas that didn't pan out. Still, researchers in the field welcome this fresh approach.

Read more
Shots - Health News
1:18 pm
Thu May 15, 2014

Medicine Needs More Research On Female Animals, NIH Says

Sex can matter, whether you're looking at drug side effects, the response to treatment, or the progression of a disease.
iStockphoto

Originally published on Thu May 15, 2014 2:22 pm

Many potential new drugs look like they could be big winners — at least when judged by how well they work in mice or other lab animals. Over the years, there have been a number of promising cancer "cures," possible Alzheimer's treatments, and candidate drugs for holding back the ravages of various degenerative diseases.

But, time after time, these great promises fade away once the potential treatments are tried in people. There are lots of reasons for that. Humans aren't rodents, for starters.

Read more

Pages